Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | TYROBP |
Upstream (Parents) |
---|
(<<) LY96 → TYROBP |
(<<) TFEC → TYROBP |
(<<) FCER1G → TYROBP |
Downstream (Children) |
---|
TYROBP → CD53 (>>) |
TYROBP → EIF4A1///CD68 (>>) |
TYROBP → FGR (>>) |
TYROBP → LILRB4 (>>) |
TYROBP → CCR1 (>>) |
TYROBP → LILRB1 (>>) |
TYROBP → DPEP2 (>>) |
TYROBP → IL21R (>>) |
TYROBP → HK3 (>>) |
TYROBP → STAP1 (>>) |
TYROBP → CD33 (>>) |
TYROBP → RENBP (>>) |
TYROBP → CD52 (>>) |
TYROBP → ZNF132 (>>) |
TYROBP → MMP23A///MMP23B (>>) |
TYROBP → CXorf21 (>>) |
TYROBP → LILRB3 (>>) |
TYROBP → YY1 (>>) |
TYROBP → SPI1 (>>) |
TYROBP → BTG3 (>>) |
TYROBP → LY96 (>>) |
TYROBP → BTK (>>) |
TYROBP → LILRA6///LILRB3 (>>) |
TYROBP → PKD2L1 (>>) |
TYROBP → FCGR1C///FCGR1A (>>) |
TYROBP → ITGB2 (>>) |
TYROBP → ADORA3 (>>) |
TYROBP → TFEC (>>) |
TYROBP → LAPTM5 (>>) |
TYROBP → FCER1G (>>) |
TYROBP → HPCA (>>) |
TYROBP → CD86 (>>) |
TYROBP → ARHGDIB (>>) |